title: Essential role of CD8+CD122+ regulatory T cells in the recovery from experimental autoimmune encephalomyelitis.
abstract: Experimental autoimmune encephalomyelitis (EAE) is one of the best-documented animal models of autoimmune disease. We examined the role of CD8+CD122+ regulatory T cells, which we previously identified as naturally occurring regulatory T cells that effectively regulate CD8+ T cells, in EAE. Depletion of CD8+CD122+ regulatory T cells by in vivo administration of anti-CD122 mAb resulted in persistent EAE symptoms. Transfer of CD8+CD122+ regulatory T cells into EAE mice at the peak EAE score clearly improved symptoms, indicating an important role of CD8+CD122+ regulatory T cells in the recovery phase of EAE. This was further confirmed by an increase and a decrease in the number of infiltrating T cells in the CNS and T cell cytokine production in mice that were depleted of or complemented with CD8+CD122+ cells. Furthermore, transfer of preactivated CD8+CD122+ regulatory T cells resulted in diminished EAE symptoms, especially in the recovery phase of EAE. These results elucidate the essential role of CD8+CD122+ regulatory T cells in the recovery phase of EAE and suggest the preventive effect of preactivated CD8+CD122+ regulatory T cells for EAE.
authors.affiliation: Department of Immunology, Nagoya University Graduate School of Medicine, Japan.
authors.forename: Young-Ho
authors.initials: YH
authors.lastname: Lee
authors.forename: Yoshiyuki
authors.initials: Y
authors.lastname: Ishida
authors.forename: Muhaimin
authors.initials: M
authors.lastname: Rifa'i
authors.forename: Zhe
authors.initials: Z
authors.lastname: Shi
authors.forename: Ken-ichi
authors.initials: K
authors.lastname: Isobe
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Suzuki
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D016827:CD8 Antigens / Q000032:analysis; D002490:Central Nervous System / Q000276:immunology / Q000473:pathology; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology* / Q000473:pathology / Q000628:therapy*; D016753:Interleukin-10 / Q000378:metabolism; D053646:Interleukin-2 Receptor beta Subunit / Q000032:analysis; D008213:Lymphocyte Activation; D008212:Lymphocyte Depletion; D051379:Mice; D008810:Mice, Inbred C57BL; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology* / Q000637:transplantation
chemical_list: D000911:Antibodies, Monoclonal; D016827:CD8 Antigens; D053646:Interleukin-2 Receptor beta Subunit; D016753:Interleukin-10